These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24317816)
21. Microsatellite instability and hMLH1 and hMSH2 expression analysis in soft tissue sarcomas. Kawaguchi K; Oda Y; Takahira T; Saito T; Yamamoto H; Kobayashi C; Tamiya S; Oda S; Iwamoto Y; Tsuneyoshi M Oncol Rep; 2005 Feb; 13(2):241-6. PubMed ID: 15643505 [TBL] [Abstract][Full Text] [Related]
22. Intronic and promoter polymorphisms of hMLH1/hMSH2 and colorectal cancer risk in Heilongjiang Province of China. Li G; Hu F; Yuan F; Fan J; Yu Z; Wu Z; Zhao X; Li Y; Li S; Rong J; Cui B; Dong X; Yuan H; Zhao Y J Cancer Res Clin Oncol; 2015 Aug; 141(8):1393-404. PubMed ID: 25560462 [TBL] [Abstract][Full Text] [Related]
23. Aberrant methylation of DNA mismatch repair genes in elderly patients with sporadic gastric carcinoma: A comparison with younger patients. Kim HG; Lee S; Kim DY; Ryu SY; Joo JK; Kim JC; Lee KH; Lee JH J Surg Oncol; 2010 Jan; 101(1):28-35. PubMed ID: 19894224 [TBL] [Abstract][Full Text] [Related]
24. hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037 [TBL] [Abstract][Full Text] [Related]
25. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma. Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278 [TBL] [Abstract][Full Text] [Related]
26. Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers. Yuen ST; Chan TL; Ho JW; Chan AS; Chung LP; Lam PW; Tse CW; Wyllie AH; Leung SY Oncogene; 2002 Oct; 21(49):7585-92. PubMed ID: 12386821 [TBL] [Abstract][Full Text] [Related]
27. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Murata H; Khattar NH; Gu L; Li GM Cancer Lett; 2005 Jun; 223(1):143-50. PubMed ID: 15890247 [TBL] [Abstract][Full Text] [Related]
28. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma. Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688 [TBL] [Abstract][Full Text] [Related]
29. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447 [TBL] [Abstract][Full Text] [Related]
30. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas. Wright CL; Stewart ID Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472 [TBL] [Abstract][Full Text] [Related]
31. Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer. Deng G; Peng E; Gum J; Terdiman J; Sleisenger M; Kim YS Br J Cancer; 2002 Feb; 86(4):574-9. PubMed ID: 11870540 [TBL] [Abstract][Full Text] [Related]
32. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. Wang YC; Lu YP; Tseng RC; Lin RK; Chang JW; Chen JT; Shih CM; Chen CY J Clin Invest; 2003 Mar; 111(6):887-95. PubMed ID: 12639995 [TBL] [Abstract][Full Text] [Related]
33. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability. Bevilacqua RA; Simpson AJ Int J Cancer; 2000 Jul; 87(2):200-3. PubMed ID: 10861474 [TBL] [Abstract][Full Text] [Related]
34. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer. Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174 [TBL] [Abstract][Full Text] [Related]
35. [Study of germline mutation of hMSH2, hMSH6 and hMLH1 and methylation of hMLH1 in microsatellite instability colorectal cancer]. Ni M; Jin HY; Ding YJ; Liu F; Ding SQ; Fan ZM; Wang YH Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):358-61. PubMed ID: 18636359 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma. Rosen DG; Cai KQ; Luthra R; Liu J Mod Pathol; 2006 Nov; 19(11):1414-20. PubMed ID: 16941012 [TBL] [Abstract][Full Text] [Related]
37. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation. Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849 [TBL] [Abstract][Full Text] [Related]
38. Defective mismatch repair and the development of recurrent endometrial carcinoma. Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202 [TBL] [Abstract][Full Text] [Related]